index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Muscular Dystrophy Cardiomyopathie MES Invivo Cell Biology NAD+ Liver L-Type Muscle Biology Mdx mouse Animal/physiopathology Multi exon skipping Cell homeostasis Dystrophin Muscle development Duchenne muscular dystrophy Inhibitors Centronuclear myopathy Exon skipping CaV subunits Activin Receptors Cardiomyopathy Cultured Gene expression Dystrophie musculaire de Becker Homeostasis Gene modifiers Cells Hepatocellular carcinoma Antisense oligonucleotides Clinical trials Muscle Strength Muscles/physiopathology Diseases MiARN Dystrophin central domain DMO Duchenne DMD dystrophy Mice Energy Metabolism/drug effects Skeletal muscle Dystrophie Musculaire de Duchenne DMD Dystrophy Inbred C57BL DMD Muscular dystrophy Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Dystrophin-EGFP Cell Line Male CTNNB1 LncARN Muscle BMD Calcium Dystrophine Animals Mitochondrial fission Long noncoding RNA CaVβs Drp1 Molecular Sequence Data Humans Morphogenesis Immunoglobulin Fc Fragments/pharmacology Delivery Gene Expression Regulation/drug effects Human Umbilical Vein Endothelial Cells Cachexia Metabolism Becker BMD muscular dystrophy Multi resolution modeling Genomic Becker muscular dystrophy BMD Autophagy NNOS Epigenetics Dynamin 2 Modificateurs de gènes Génomique LKB1 Long QT Muscular Atrophy Becker muscular dystrophy Myotendinous junction Myogenesis Molecular docking Base Sequence Ex-vivo Knockout DHPR α1S Calcium Channels LncRNA Hear Inbred mdx Duchenne muscular dystrophy DMD Multiresolution modeling Dystrophie Musculaire de Becker BMD CD38 Allele‐specific silencing therapy